Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00389350 · ClinicalTrials.gov registry record · Phase 2

Effect of an Extract of Green Tea on Adults With Type 2 Diabetes

A Phase 2 study, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
Phase 2
Development phase
48
Enrollment target

NCT00389350 is a Phase 2 study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 48 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00389350, a Phase 2 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
Phase 2
Development phase
48 participants
Enrollment target

Study Summary

The objective of this study was to determine if taking an extract of green tea for three months could improve glucose control in adults with diabetes.

Interventions

  • DRUG Extract of Green and Black Tea

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2005-08
Est. Completion 2006-06
Phase Phase 2

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT00389350

The ClinicalTrials.gov registry entry for NCT00389350 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Extract of Green and Black Tea is the first listed.

NCT00389350 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00389350 about?

NCT00389350 is a clinical study titled "Effect of an Extract of Green Tea on Adults With Type 2 Diabetes". The objective of this study was to determine if taking an extract of green tea for three months could improve glucose control in adults with diabetes.

What is the current status of trial NCT00389350?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2005-08. Estimated completion is 2006-06.

What interventions are being tested in trial NCT00389350?

The interventions under investigation include: Extract of Green and Black Tea (DRUG).

Who is sponsoring clinical trial NCT00389350?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.